The estimated Net Worth of James P Shaffer is at least 958 千$ dollars as of 18 August 2016. Mr. Shaffer owns over 3,125 units of Eiger BioPharmaceuticals Inc stock worth over 9,695$ and over the last 13 years he sold EIGR stock worth over 0$. In addition, he makes 948,587$ as Chief Business Officer at Eiger BioPharmaceuticals Inc.
Sign up
Mr. Shaffer EIGR stock SEC Form 4 insiders trading
James has made over 6 trades of the Eiger BioPharmaceuticals Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 3,125 units of EIGR stock worth 49,063$ on 18 August 2016.
The largest trade he's ever made was buying 20,000 units of Eiger BioPharmaceuticals Inc stock on 14 November 2012 worth over 104,400$. On average, James trades about 3,138 units every 81 days since 2012. As of 18 August 2016 he still owns at least 5,620 units of Eiger BioPharmaceuticals Inc stock.
You can see the complete history of Mr. Shaffer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
James Shaffer biography
James Shaffer serves as Chief Business Officer of the Company. He served as the Chief Business Officer of Private Eiger from September 2015 until the completion of the Merger in March 2016, having previously served as a consultant to Private Eiger from August 2014 through September 2015. Since the completion of the Merger, Mr. Shaffer has served as our Chief Business Officer. Prior to his time at Private Eiger, Mr. Shaffer was Vice President and Chief Commercial Officer at Halozyme Therapeutics from 2011 to 2014 and Executive Vice President and Chief Commercial Officer at Clinical Data Inc. from 2007 to 2011. Prior to those positions, Mr. Shaffer held a series of different sale and product related positions of increasing responsibility at multiple pharmaceutical companies. Mr. Shaffer earned a B.S. in Agriculture Economics and a M.B.A. from the Ohio State University.
What is the salary of James Shaffer?
As the Chief Business Officer of Eiger BioPharmaceuticals Inc, the total compensation of James Shaffer at Eiger BioPharmaceuticals Inc is 948,587$. There are 5 executives at Eiger BioPharmaceuticals Inc getting paid more, with David Cory having the highest compensation of 2,871,850$.
How old is James Shaffer?
James Shaffer is 53, he's been the Chief Business Officer of Eiger BioPharmaceuticals Inc since 2015. There are 13 older and 5 younger executives at Eiger BioPharmaceuticals Inc. The oldest executive at Eiger BioPharmaceuticals Inc is Dr. Colin Hislop, 63, who is the Sr. VP of Clinical & Devel. Operations.
What's James Shaffer's mailing address?
James's mailing address filed with the SEC is C/O EIGER BIOPHARMACEUTICALS, INC., 2155 PARK BLVD., PALO ALTO, CA, 94306.
Insiders trading at Eiger BioPharmaceuticals Inc
Over the last 9 years, insiders at Eiger BioPharmaceuticals Inc have traded over 3,017,304$ worth of Eiger BioPharmaceuticals Inc stock and bought 780,533 units worth 4,706,203$ . The most active insiders traders include Richard A Kayne、Edgar Engleman、Partners X Lp Inter West Ma.... On average, Eiger BioPharmaceuticals Inc executives and independent directors trade stock every 70 days with the average trade being worth of 47,232$. The most recent stock trade was executed by Richard A Kayne on 31 October 2023, trading 278,239 units of EIGR stock currently worth 72,342$.
What does Eiger BioPharmaceuticals Inc do?
eiger inc is a research company located in 500 crescent ct ste 300, dallas, texas, united states.
What does Eiger BioPharmaceuticals Inc's logo look like?
Complete history of Mr. Shaffer stock trades at Eiger BioPharmaceuticals Inc、Halozyme Therapeutics
Eiger BioPharmaceuticals Inc executives and stock owners
Eiger BioPharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
David Cory,
President, Chief Executive Officer, Director -
David Apelian,
Director -
Stephana Patton,
Chief Compliance Officer, General Counsel, Corporate Secretary -
Sriram Ryali,
Chief Financial Officer -
David A. Cory M.B.A., R.Ph., R.Ph, MBA,
Bus. Founder, Pres, CEO & Director -
James Shaffer,
Chief Business Officer -
David A. Cory R.Ph, MBA,
Bus. Founder, Pres, CEO & Director -
Eldon C. Mayer III, M.B.A.,
Exec. VP & Chief Commercial Officer -
Sriram Ryali M.B.A.,
Chief Financial Officer -
Christine Murray,
Independent Director -
Thomas Dietz,
Independent Chairman of the Board -
Amit Sachdev,
Independent Director -
Evan Loh,
Independent Director -
Eldon Mayer,
Executive Vice President, Chief Commercial Officer -
Jeffrey Glenn,
Independent Director -
Dr. Evan Loh,
CEO of Paratek Pharmaceuticals & Director -
Dr. Jeffrey S. Glenn,
Founder, Scientific Advisor & Independent Director -
Dr. Stephana E. Patton J.D., Ph.D.,
Consultant -
Erik Atkisson,
Gen. Counsel, Corp. Sec. & Chief Compliance Officer -
Dr. Colin Hislop,
Sr. VP of Clinical & Devel. Operations -
Rich Franco M.B.A.,
Sr. VP & Progeria Program Lead -
Dr. Ingrid C. Choong,
Sr. VP of Clinical Devel. -
Charles Bramlage,
Director -
Edgar Engleman,
Director -
Joanne Quan,
Chief Medical Officer -
Eduardo Bruno Martins,
SVP, Liver and Infectious Dise -
Ventures Vi, Llc Vivo Ventu...,
-
James H Welch,
Chief Financial Officer -
Nina S Kjellson,
Director -
Kim Sablich,
-
Partners X Lp Inter West Ma...,
-
Ingrid Choong,
Chief Business Officer -
Erik Atkisson,
GC & Chief Compliance Officer -
Lisa Kelly Croswell,
-
James Vollins,
General Counsel -
Leen Kawas,
-
Richard A Kayne,